ARCHIVES

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

This article is from The Cancer Letter archive.

Vol. 17 No. 10 | March 8, 1991

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

Patient Advocacy: MBCC Conference Issues Statement On Equal Status On Advocates

April 4, 1997

In Brief: AMA Issues Guidelines For HIV Infection, Smoking Cessation; MDA Appointment

February 4, 1994

Greatest Need Of Cancer Care Givers: “Will to Work Together,” ACCC President Anderson Says

August 15, 1986

NCAB Approves OIA Awards For At Least 21 Scientist, More If Payline Lifted

May 24, 1985

MIT’s Sharp To Head Biology Dept.; Hynes To Head Cancer Center

April 12, 1991